Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Xenon Pharmaceuticals (XENE) has a market cap of $3.01 billion USD. According to our data, Xenon Pharmaceuticals is ranked No.3486 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $3.01 B |
0.59%
|
| Dec 31, 2024 | $2.99 B |
-14.89%
|
| Dec 29, 2023 | $3.51 B |
16.81%
|
| Dec 30, 2022 | $3.01 B |
26.22%
|
| Dec 31, 2021 | $2.38 B |
103.12%
|
| Dec 31, 2020 | $1.17 B |
17.32%
|
| Dec 31, 2019 | $1.00 B |
107.77%
|
| Dec 31, 2018 | $0.48 B |
123.36%
|
| Dec 29, 2017 | $0.22 B |
-63.31%
|
| Dec 30, 2016 | $0.59 B |
-4.23%
|
| Dec 31, 2015 | $0.61 B |
-59.29%
|
| Dec 31, 2014 | $1.51 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Sage Therapeutics
SAGE
|
$0.43 B |
0.000 M
|
USA
|
 Biohaven Pharmaceutical
BHVN
|
$4.09 B |
0.000 M
|
USA
|
 Marinus Pharmaceuticals
MRNS
|
$29.94 M |
0.000 M
|
USA
|
 Supernus Pharmaceuticals
SUPN
|
$2.10 B |
0.000 M
|
USA
|
 Axsome Therapeutics
AXSM
|
$4.90 B |
0.000 M
|
USA
|
 Ovid Therapeutics
OVID
|
$51.66 M |
0.000 M
|
USA
|
 Praxis Precision Medicines
PRAX
|
$1.49 B |
0.000 M
|
USA
|
 ACADIA Pharmaceuticals
ACAD
|
$2.97 B |
0.000 M
|
USA
|
 Intra-Cellular Therapies
ITCI
|
$13.51 B |
0.000 M
|
USA
|
 Alkermes
ALKS
|
$4.90 B |
0.000 M
|
Ireland
|
 Jazz Pharmaceuticals
JAZZ
|
$7.35 B |
-0.000 M
|
Ireland
|
| Market Cap | = | XENE Stock Price | * | XENE Shares Outstanding |
| = | $39.43 | * | 76.24 M | |
| = | $3.01 B |